Non-Applicability of Reg.57(5) of SEBI (LODR) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek Ltd has informed BSE that Regulation 57(5) of SEBI (LODR) Regulations, 2015 does not apply to the company for the quarter ended 30th June 2025. The regulation requires companies with non-convertible securities to submit certificates regarding payment of interest, dividend, or principal obligations. The company has clarified that it has not issued any non-convertible securities, making this compliance requirement inapplicable. The letter was signed by Dr K Koteswara Rao, Chairman & Managing Director.
This is a routine quarterly compliance clarification with no material impact on shareholders or the stock price. It simply confirms the company has no non-convertible debt obligations to report on.